Raphael Ognar

Company: NKILT Therapeutics

Job title: President, Chief Executive Officer & Co-Founder

Seminars:

Exploring the Different Cell Types & Their Advantages in Targeting Tumors to Ensure Success 9:30 am

Comparing NK cells, TILs, Gamma Delta cells, Macrophages and more Understanding the best cell type for your developmentRead more

day: Cell Therapy Fundamentals Day

1:00pm Workshop D: Building Differentiated Preclinical Strategies for Novel Cell Therapies and Emerging Modalities 1:00 pm

While CAR-T dominates current approvals, advancing novel modalities such as NK, γδ T, or iNKT cells could present a new set of challenges. New targets, engineering approaches, and the pursuit of greater efficacy with improved safety require strong and well documented preclinical evidence. The integration of predictive biomarkers, AI, and other technologies adds value but…Read more

day: Workshop Day Track B P2